[1] CARMEN M H, CABALLERO E C, VERONICA S L, et al. Nutriepigenomics and chronic obstructive pulmonary disease: potential role of dietary and epigenetics factors in disease development and management[J]. Am J Clin Nutr, 2021, 114(6):1894-1906. [2] HUANG Q, LI C D, YANG Y R, et al. Role of the IL-33/ST2 axis in cigarette smoke-induced airways remodelling in chronic obstructive pulmonary disease[J]. Thorax, 2021,15(2): 214712. [3] FUKUDA K, MATSUZAKI H, YU M, et al. A mouse model of asthma-chronic obstructive pulmonary disease overlap induced by intratracheal papain[J]. Allergy, 2021, 76(1):390-394. [4] 徐娟,吴晓飞.经鼻加温湿化高流量氧疗与无创辅助通气治疗慢性阻塞性肺疾病的临床效果分析[J].蚌埠医学院学报,2021,46(5):627-629,634. [5] 李文英,曾瑜,汪得喜,等.血清颗粒蛋白前体水平与慢性阻塞性肺疾病急性加重期患者肺功能及病情严重程度的关系[J].中国医药,2021,16(5):697-700. [6] 中华医学会呼吸病学会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南[J]. 中华内科杂志, 2002, 25(8):640-646. [7] LIU H, TANG H Y, XU J Y, et al. Small airway immunoglobulin a profile in emphysema-predominant chronic obstructive pulmonary disease[J]. Chin Med J, 2020, 133(16):1915-1921. [8] 罗月,葛伟婷,张帅,等.ICU经鼻高流量湿化氧疗患者早期舒适度评估及管理方案构建[J].中国实用护理杂志,2020,36(19):1467-1473. [9] 雷芳,龚霞.中性粒细胞型哮喘患儿急性发作期血清颗粒蛋白前体与疾病严重程度及气道炎症的关系[J].东南大学学报(医学版),2021,40(3):324-330. [10] 李文英,曾瑜,汪得喜,等.血清颗粒蛋白前体水平与慢性阻塞性肺疾病急性加重期患者肺功能及病情严重程度的关系[J].中国医药,2021,16(5):697-700. [11] 沈妙文,杨月霞,李娟,等.血清miR-34b-5p和颗粒体蛋白前体水平与急性呼吸窘迫综合征患儿病情严重程度和预后的关系[J].中华实用诊断与治疗杂志,2021,35(6):603-606. |